Utsunomiya, Japan

Kazuyuki Shimada




Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Tochigi, JP (2013)
  • Utsunomiya, JP (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Kazuyuki Shimada: Innovator in Cardiology**

Introduction

Kazuyuki Shimada, located in Utsunomiya, Japan, is a noted inventor with a specialized focus on cardiovascular health. He holds two patents that contribute significantly to the medical field, specifically in the prevention and management of cardiovascular events. His research and innovations have the potential to improve therapeutic outcomes for patients.

Latest Patents

Shimada's latest patents include a composition and method for preventing the onset and recurrence of cardiovascular events. These compositions are particularly aimed at patients who have stabilized after undergoing cardiovascular angioplasty or those suffering from hyperlipidemia who have been treated with HMG-CoA reductase inhibitors (HMG-CoA RI). By addressing these specific patient needs, his work represents a meaningful advancement in cardiovascular care.

Career Highlights

Kazuyuki Shimada is currently employed at Mochida Pharmaceutical Co., Ltd., where he continues to refine his research and develop innovative solutions in the medical field. His contributions to cardiology are underscored by his dual patents, showcasing his commitment to enhancing patient care through scientific discovery.

Collaborations

In his career, Shimada has collaborated with prominent colleagues, including Mitsuhiro Yokoyama and Hideki Origasa. Together, they form a collaborative team that fosters innovation and drives forward-thinking research in cardiovascular solutions.

Conclusion

In summary, Kazuyuki Shimada is a remarkable inventor whose work in the realm of cardiovascular health stands as a testament to the impact that dedicated research and innovation can have in medicine. With two significant patents to his name and a role at Mochida Pharmaceutical Co., Ltd., he continues to forge pathways that improve patient outcomes in the field of cardiovascular treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…